Accordingly, a synthetic lethal relationship between CHK1 inhibition and TP53 deficiency has been observed in soft-tissue sarcomas, but not TP53-WT undifferentiated pleomorphic sarcoma (UPS) models, which was associated with an increased proportion of cells with DNA damage [522]. Here, TP53 is linked to soft tissue sarcoma.